HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Asami Mori Selected Research

Drinking Water

1/2019Probucol Slows the Progression of Cataracts in Streptozotocin-Induced Hyperglycemic Rats.
1/2018Anti-cataract Effect of Resveratrol in High-Glucose-Treated Streptozotocin-Induced Diabetic Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Asami Mori Research Topics

Disease

24Ganglion Cysts (Ganglion)
10/2023 - 08/2009
10Glaucoma
01/2024 - 08/2009
9Retinal Diseases
01/2018 - 08/2009
8Diabetic Retinopathy (Retinopathy, Diabetic)
01/2023 - 08/2009
7Ischemia
10/2023 - 11/2010
6Cataract (Cataracts)
01/2019 - 10/2008
6Retinal Degeneration
01/2019 - 11/2010
5Hypoxia (Hypoxemia)
01/2020 - 03/2014
4Pathologic Neovascularization
01/2024 - 01/2014
4Retinopathy of Prematurity (Retrolental Fibroplasia)
08/2021 - 02/2016
4Diabetes Mellitus
03/2021 - 08/2008
4Hyperglycemia
01/2019 - 06/2009
4Inflammation (Inflammations)
12/2018 - 08/2009
3Neoplasms (Cancer)
01/2020 - 12/2012
3Reperfusion Injury
08/2015 - 03/2014
3Fetal Growth Retardation (Intrauterine Growth Retardation)
08/2014 - 08/2013
3Hyperalgesia
01/2014 - 12/2012
2Diabetes Complications
01/2023 - 01/2018
2Premature Birth (Birth, Premature)
08/2021 - 02/2013
2Vascular Diseases (Vascular Disease)
08/2021 - 05/2015
2Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2018 - 01/2011
2Hyperoxia
12/2016 - 10/2015
2Congenital Hypothyroidism (Cretinism)
04/2016 - 11/2008
2Hypothyroidism
04/2016 - 11/2008
2Wounds and Injuries (Trauma)
10/2013 - 08/2009
2Neuralgia (Stump Neuralgia)
01/2013 - 12/2012
2Crigler-Najjar Syndrome
11/2004 - 11/2003
1Optic Neuritis (Retrobulbar Neuritis)
03/2024
1Dysphonia (Spastic Dysphonia)
03/2024
1Hemoptysis
03/2024
1Fatigue
03/2024
1Lung Diseases (Lung Disease)
03/2024
1Leukemia
01/2024
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2024
1Lymphoma (Lymphomas)
01/2024
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020
1Uveitis
12/2018
1Chronic Disease (Chronic Diseases)
01/2018

Drug/Important Bio-Agent (IBA)

33Retinaldehyde (Retinal)IBA
01/2024 - 06/2007
27N-Methylaspartate (NMDA)IBA
01/2024 - 08/2009
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 02/2013
9Glutamic Acid (Glutamate)FDA Link
01/2018 - 08/2009
6Vasodilator Agents (Vasodilators)IBA
08/2021 - 06/2007
6Streptozocin (Streptozotocin)FDA Link
01/2019 - 08/2008
5Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2018 - 08/2013
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017 - 11/2010
3Oxygen (Dioxygen)IBA
01/2024 - 01/2014
3ResveratrolIBA
10/2023 - 09/2011
3Acetylcholine (Acetylcholine Chloride)FDA Link
02/2015 - 06/2009
3N- (2- chloro- 4- ((6,7- dimethoxy- 4- quinazolinyl)oxy)phenyl)- N'- propylureaIBA
08/2014 - 02/2013
3bilirubin glucuronoside glucuronosyltransferaseIBA
07/2014 - 11/2003
3Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2014 - 12/2012
3elcatoninIBA
01/2014 - 12/2012
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2014 - 12/2012
2MicroRNAs (MicroRNA)IBA
01/2024 - 01/2020
2Pyruvaldehyde (Methylglyoxal)IBA
01/2023 - 01/2018
2ParvalbuminsIBA
04/2021 - 10/2013
2Crystallins (Crystallin)IBA
01/2019 - 01/2018
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 01/2018
2Drinking WaterIBA
01/2019 - 01/2018
2Probucol (Lorelco)FDA Link
01/2019 - 12/2017
2Purinergic P2X7 ReceptorsIBA
12/2018 - 06/2015
2Opioid Receptors (Opioid Receptor)IBA
01/2018 - 10/2017
2Capsaicin (Zostrix)FDA Link
10/2017 - 06/2014
2Dual OxidasesIBA
04/2016 - 11/2008
2Sirolimus (Rapamycin)FDA Link
01/2015 - 01/2014
2EverolimusFDA Link
01/2015 - 01/2014
2Tyrosine Kinase InhibitorsIBA
08/2014 - 08/2013
2BilirubinIBA
07/2014 - 04/2005
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2013 - 02/2013
2Paclitaxel (Taxol)FDA LinkGeneric
01/2013 - 12/2012
2polyolIBA
01/2012 - 01/2010
2BradykininIBA
09/2011 - 01/2011
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2011 - 04/2010
1CreatinineIBA
03/2024
1C-Reactive ProteinIBA
03/2024
1Liposomes (Liposome)IBA
03/2024
1SuspensionsIBA
03/2024
1Amikacin (A.M.K)FDA LinkGeneric
03/2024
1Ethambutol (Myambutol)FDA LinkGeneric
03/2024
1Metformin (Glucophage)FDA LinkGeneric
01/2024
1Mechanistic Target of Rapamycin Complex 1IBA
01/2024
1mouse MIRN29 microRNAIBA
01/2024
1Complement System Proteins (Complement)IBA
01/2024
1Proteins (Proteins, Gene)FDA Link
01/2024
1Bcl-2-Like Protein 11IBA
01/2024
1Advanced Glycation End ProductsIBA
01/2023
1CitrullineIBA
03/2021
1Calbindin 2IBA
04/2019
1LipidsIBA
01/2019
1AntioxidantsIBA
01/2019
1Hypolipidemic Agents (Antihyperlipidemics)IBA
01/2019
1SugarsIBA
01/2019
1Neuroprotective AgentsIBA
12/2018
1coomassie Brilliant BlueIBA
12/2018
1EndotoxinsIBA
12/2018
1Nitric Oxide Synthase (NO Synthase)IBA
01/2018

Therapy/Procedure

11Intravitreal Injections
01/2024 - 01/2013
4Therapeutics
03/2024 - 01/2011
1Duration of Therapy
03/2024